270 related articles for article (PubMed ID: 23472708)
1. Longterm survival after pancreaticoduodenectomy for periampullary adenocarcinomas.
Chen SC; Shyr YM; Wang SE
HPB (Oxford); 2013 Dec; 15(12):951-7. PubMed ID: 23472708
[TBL] [Abstract][Full Text] [Related]
2. Predictors of long-term survival after pancreaticoduodenectomy for peri-ampullary adenocarcinoma: A retrospective study of 5-year survivors.
El Nakeeb A; El Sorogy M; Ezzat H; Said R; El Dosoky M; Abd El Gawad M; Elsabagh AM; El Hanafy E
Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):443-449. PubMed ID: 30126828
[TBL] [Abstract][Full Text] [Related]
3. Palliative pancreaticoduodenectomy in pancreatic and periampullary adenocarcinomas.
Wang SE; Shyr YM; Su CH; Chen TH; Wu CW
Pancreas; 2012 Aug; 41(6):882-7. PubMed ID: 22286381
[TBL] [Abstract][Full Text] [Related]
4. Pancreatobiliary versus intestinal histologic type of differentiation is an independent prognostic factor in resected periampullary adenocarcinoma.
Westgaard A; Tafjord S; Farstad IN; Cvancarova M; Eide TJ; Mathisen O; Clausen OP; Gladhaug IP
BMC Cancer; 2008 Jun; 8():170. PubMed ID: 18547417
[TBL] [Abstract][Full Text] [Related]
5. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality.
Yeo CJ; Cameron JL; Lillemoe KD; Sohn TA; Campbell KA; Sauter PK; Coleman J; Abrams RA; Hruban RH
Ann Surg; 2002 Sep; 236(3):355-66; discussion 366-8. PubMed ID: 12192322
[TBL] [Abstract][Full Text] [Related]
6. Periampullary adenocarcinoma: analysis of 5-year survivors.
Yeo CJ; Sohn TA; Cameron JL; Hruban RH; Lillemoe KD; Pitt HA
Ann Surg; 1998 Jun; 227(6):821-31. PubMed ID: 9637545
[TBL] [Abstract][Full Text] [Related]
7. Pancreaticoduodenectomy for periampullary cancer: does the tumour entity influence perioperative morbidity and long-term outcome?
Wiltberger G; Krenzien F; Atanasov G; Hau HM; Schmelzle M; Bartels M; Benzing C
Acta Chir Belg; 2018 Dec; 118(6):341-347. PubMed ID: 30203717
[TBL] [Abstract][Full Text] [Related]
8. Effect of Pancreatic Fistula on Recurrence and Long-Term Prognosis of Periampullary Adenocarcinomas after Pancreaticoduodenectomy.
Serrano PE; Kim D; Kim PT; Greig PD; Moulton CA; Gallinger S; Wei AC; Cleary SP
Am Surg; 2016 Dec; 82(12):1187-1195. PubMed ID: 28234183
[TBL] [Abstract][Full Text] [Related]
9. Extended lymph node resection versus standard resection for pancreatic and periampullary adenocarcinoma.
Staerkle RF; Vuille-Dit-Bille RN; Soll C; Troller R; Samra J; Puhan MA; Breitenstein S
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD011490. PubMed ID: 33471373
[TBL] [Abstract][Full Text] [Related]
10. Predictors of survival in periampullary cancers following pancreaticoduodenectomy.
Hatzaras I; George N; Muscarella P; Melvin WS; Ellison EC; Bloomston M
Ann Surg Oncol; 2010 Apr; 17(4):991-7. PubMed ID: 20108122
[TBL] [Abstract][Full Text] [Related]
11. Impact of lymph node ratio on survival in patients with pancreatic and periampullary cancer.
Tol JA; Brosens LA; van Dieren S; van Gulik TM; Busch OR; Besselink MG; Gouma DJ
Br J Surg; 2015 Feb; 102(3):237-45. PubMed ID: 25529117
[TBL] [Abstract][Full Text] [Related]
12. Cyclin D1 and bax influence the prognosis after pancreatoduodenectomy for periampullary adenocarcinoma.
Tomazic A; Pegan V; Ferlan-Marolt K; Pleskovic A; Luzar B
Hepatogastroenterology; 2004; 51(60):1832-7. PubMed ID: 15532837
[TBL] [Abstract][Full Text] [Related]
13. Assessment of survival advantage in ampullary carcinoma in relation to tumour biology and morphology.
Morris-Stiff G; Alabraba E; Tan YM; Shapey I; Bhati C; Tanniere P; Mayer D; Buckels J; Bramhall S; Mirza DF
Eur J Surg Oncol; 2009 Jul; 35(7):746-50. PubMed ID: 19167859
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of intratumoural microvessel density (IMD) in resected pancreatic and ampullary cancers to standard histopathological variables and survival.
Khan AW; Dhillon AP; Hutchins R; Abraham A; Shah SR; Snooks S; Davidson BR
Eur J Surg Oncol; 2002 Sep; 28(6):637-44. PubMed ID: 12359201
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of prognosis-associated factors in pancreatic head and peri-ampullary cancer].
Roder JD; Siewert JR
Chirurg; 1992 May; 63(5):410-5. PubMed ID: 1376655
[TBL] [Abstract][Full Text] [Related]
16. Pylorus-preserving pancreatoduodenectomy. Is it an adequate cancer operation.
Tsao JI; Rossi RL; Lowell JA
Arch Surg; 1994 Apr; 129(4):405-12. PubMed ID: 7908796
[TBL] [Abstract][Full Text] [Related]
17. Implications of histological grade of tumour for the prognosis of radically resected periampullary adenocarcinoma.
Sellner FJ; Riegler FM; Machacek E
Eur J Surg; 1999 Sep; 165(9):865-70. PubMed ID: 10533763
[TBL] [Abstract][Full Text] [Related]
18. Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: comparison of morbidity and mortality and short-term outcome.
Yeo CJ; Cameron JL; Sohn TA; Coleman J; Sauter PK; Hruban RH; Pitt HA; Lillemoe KD
Ann Surg; 1999 May; 229(5):613-22; discussion 622-4. PubMed ID: 10235519
[TBL] [Abstract][Full Text] [Related]
19. [Results of pancreaticoduodenectomy in the treatment of periampullary tumors].
Norero E; Viñuela E; Báez S; Martínez C; Reyes J; Kusanovic R; Sanhueza M; Aguayo G; Calvo A; Mege RM; Caracci M; Díaz A
Rev Med Chil; 2011 Aug; 139(8):1015-24. PubMed ID: 22215331
[TBL] [Abstract][Full Text] [Related]
20. Survival analysis after pancreatic resection for ampullary and pancreatic head carcinoma: an analysis of clinicopathological factors.
Sommerville CA; Limongelli P; Pai M; Ahmad R; Stamp G; Habib NA; Williamson RC; Jiao LR
J Surg Oncol; 2009 Dec; 100(8):651-6. PubMed ID: 19722229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
